# Biocodex – FDA Inspection, May 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/biocodex/4f41d61d-6ab3-483d-8c92-386fdbbb0172
Source feed: FDA_Inspections

> FDA inspection 1053229 of Biocodex, May 25, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053229
- Company Name: Biocodex
- Inspection Date: 2018-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- FDA Inspection 1283742 - 2022-06-17
- FDA Inspection 1135732 - 2020-01-23
- [FDA Inspection 992497 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/biocodex/3c684a3b-f534-43b8-953e-88dea75a3a5c)
- FDA Inspection 986993 - 2016-09-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)

Company: https://www.keypedia.com/companies/biocodex/1073e05a-a897-45c2-8b1e-96f23d086a72

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
